IL-2-stimulated splenocytes reduce infections by Leishmania donovani in vivo

Journal of Parasitology

Volumn 82, Issue 1, 1996, Pages 78-81

  Olivier, Martin ^a,b   Eslami, Zohreh ^a   Tanner, Charles E ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CELL TRANSFER; DOWN REGULATION; INFECTION CONTROL; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; SPLEEN CELL;

ANIMALS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; MALE; MICE; MICE, INBRED C57BL; SPLEEN;

ANIMALIA; LEISHMANIA DONOVANI; NASO HEXACANTHUS; PROTOZOA;

EID: 0029869836     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.2307/3284119     Document Type: Article

References (20)

1. BERMAN, J. D., J. D. CHULAY, L. D. HENDRICKS, AND C. N. OSTER. 1982. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. American Journal of Tropical Medicine and Hygiene 31: 459-465.
2. BRADLEY, D. J., AND J. KIRKLEY. 1977. Regulation of Leishmania donovani infections in mice. Clinical and Experimental Immunology 30: 119-129.
3. CHANG, K. P., AND J. W. CHIAO. 1981. Cellular immunity in mice to Leishmania donovani in vitro: Lymphokine-mediated killing of intracellular parasites in macrophages. Proceedings of the National Academy of Sciences USA 78: 7083-7087.
4. CHEEVER, M. A., P. D. GREENBERG, A. FEFER, AND A. GILLIS. 1982. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin-2. Journal of Experimental Medicine 155: 968-990.
5. ESLAMI, Z., M. OLIVIER, AND C. E. TANNER. 1995. Immunotherapy with IL-2-stimulated splenocytes reduces in vitro the level of Leishmania donovani infection in peritoneal macrophages. International Journal for Parasitology 25: 975-981.
6. _, AND C. E. TANNER. 1994. Time course and intensity of infection in vitro in the resident peritoneal macrophages of resistant and susceptible mice exposed to different doses of Leishmania donovani promastigotes. International Journal for Parasitology 24: 743-747.
7. HENDERSON, L. E., J. E. HEWELSON, R. F. HOPKINS, R. C. SOWDER, R. H. NEUBAUER, AND H. RABIN. 1983. A rapid, large scale purification procedure for gibbon interleukin-2. Journal of Immunology 131: 810-815.
8. MISHELL, B. B., AND S. M. SHIIGI. 1980. Selected methods in cellular immunology. W. H. Freeman & Company, San Francisco, California, p 23.
9. MULE, J. J., S. SHU, AND S. A. ROSENBERG. 1985. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo. Journal of Immunology 135: 646-652.
10. MURRAY, H. W., G. D. MIRALLES, M. Y. STOECKLE, AND D. F. McDERMOTT. 1993. Role and effect of IL-2 in experimental visceral leishmaniasis. Journal of Immunology 151: 929-938.
11. _, J. J. STERN, K. WELTE, B. H. RUBIN, S. M. CARRIERO, AND C. F. NATHAN. 1987. Experimental visceral leishmaniasis: Production of interleukin-2 and interferon-gamma, tissue immune reaction and response to treatment with interleukin-2 and interferongamma. Journal of Immunology 138: 2290-2297.
12. NACY, C. A., M. A. MELTZER, E. J. LEONARD, AND D. J. WYLER. 1981. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages. Journal of Immunology 127: 2381-2386.
13. NICKOL, A. D., AND P. F. BONVENTRE. 1985. Visceral leishmaniasis in congenic mice of susceptible and resistant phenotype: Immunosuppression by adherent spleen cells. Infection and Immunity 50: 160-168.
14. OLIVIER, M., S. BERTRAND, AND C. E. TANNER. 1989. Killing of Leishmania donovani by activated liver macrophages from resistant and susceptible strains of mice. International Journal for Parasitology 19: 377-383.
15. _, AND C. E. TANNER. 1987. Susceptibility of macrophage populations to infection in vitro by Leishmania donovani. Infection and Immunity 55: 467-471.
16. _, AND _. 1989. The effect of cyclosporin A in murine visceral leishmaniasis. Tropical Medicine and Parasitology 40: 32-38.
17. REED, S. G., J. A. INVERSO, AND S. P. ROTERS. 1984. Heterologous antibody responses in mice with chronic T. cruzi infection: Depressed T helper function restored with supernatant containing interleukin-2. Journal of Immunology 133: 1558-1563.
18. REINER, N. E., AND J. H. FINKE. 1983. Interleukin-2 deficiency in murine leishmaniasis donovani and its relationship to depressed spleen cell response to phytohemagglutinin. Journal of Immunology 131: 1487-1491.
19. ROSENBERG, S. A., P. SPIESS, AND R. LAFRENIERE. 1986. A new approach, to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318-1321.
20. SHARMA, S. D., J. M. HOFFLIN, AND J. S. REMINGTON. 1985. In vivo recombinant interleukin-2 administration enhances survival against a lethal challenge with Toxoplasma gondii. Journal of Immunology 135: 4160-4163.